Literature DB >> 12218116

Major differences in antigen-processing correlate with a single Arg71<-->Lys substitution in HLA-DR molecules predisposing to rheumatoid arthritis and with their selective interactions with 70-kDa heat shock protein chaperones.

Sabine Roth1, Nicholas Willcox, Rita Rzepka, Matthias P Mayer, Inga Melchers.   

Abstract

Several HLA-DR alleles are genetically associated with rheumatoid arthritis. DRB1*0401 predominates in Northern Europe and has a characteristic (70)QKRAA motif. This sequence contacts bound peptides and the TCR. Further interactions have been suggested with additional proteins during Ag loading. We explored the much stronger processing/presentation of full-length recombinant human acetylcholine receptor alpha subunit to a specific T cell clone by APC from DRB1*0401+ than *0408+ donors. Using DR*04 transfectants, we show that this difference results largely from the single Lys71<-->Arg interchange (0401<-->0408), which scarcely affects epitope binding, rather than from any other associated polymorphism. Furthermore, we proved our recombinant polypeptides to contain the Escherichia coli 70-kDa heat shock protein molecule DnaK and its requirement for efficient processing and presentation of the epitope by DRB1*0401+ cells. According to a recent report, 70-kDa heat shock protein chaperones preferentially bind to the QKRAA, rather than the QRRAA, motif. Variations between the shared epitope motifs QKRAA and QRRAA are emphasized by underlining. We propose that such interactions enhance the intracellular epitope loading of *0401 molecules. They may thus broaden immune responses to pathogens and at least partially explain the distinct contributions of DRB1*0401 and other alleles to disease predisposition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218116     DOI: 10.4049/jimmunol.169.6.3015

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Interaction between HSP73 and HLA-DRB1*0401: implications for the development of rheumatoid arthritis.

Authors:  Isabelle Auger; Jean Roudier
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  [Immunogenetics--HLA-association, molecular chaperones and "related" diseases].

Authors:  I Melchers
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

Review 3.  Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging.

Authors:  Marie-Pierre Hinault; Anat Ben-Zvi; Pierre Goloubinoff
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.

Authors:  Isabelle Auger; Chantal Roudier; Sandrine Guis; Nathalie Balandraud; Jean Roudier
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

5.  High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK.

Authors:  Volker Burkart; Rahel K Siegenthaler; Elias Blasius; Koen Vandenbroeck; Iraide Alloza; Waltraud Fingberg; Nanette C Schloot; Philipp Christen; Hubert Kolb
Journal:  BMC Biochem       Date:  2010-11-08       Impact factor: 4.059

6.  Cd40 but not CD154 knockout mice have reduced inflammatory response in polymicrobial sepsis: a potential role for Escherichia coli heat shock protein 70 in CD40-mediated inflammation in vivo.

Authors:  Anna Nolan; Michael D Weiden; Yoshihiko Hoshino; Jeffrey A Gold
Journal:  Shock       Date:  2004-12       Impact factor: 3.454

7.  PAD2 immunization induces ACPA in wild-type and HLA-DR4 humanized mice.

Authors:  Marie F Hemon; Nathalie C Lambert; Jean Roudier; Isabelle Auger
Journal:  Eur J Immunol       Date:  2022-06-25       Impact factor: 6.688

8.  In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.

Authors:  Guillaume Larid; Mikael Pancarte; Géraldine Offer; Cyril Clavel; Marielle Martin; Vincent Pradel; Isabelle Auger; Pierre Lafforgue; Jean Roudier; Guy Serre; Nathalie Balandraud
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.